BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3136650)

  • 1. Combined gonadotropin-releasing hormone analog and exogenous gonadotropins for ovulation induction in infertile women: efficacy related to ovarian function assessment.
    Fleming R; Haxton MJ; Hamilton MP; Conaghan CJ; Black WP; Yates RW; Coutts JR
    Am J Obstet Gynecol; 1988 Aug; 159(2):376-81. PubMed ID: 3136650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of ovulation in polycystic ovarian disease.
    Fleming R
    Prog Clin Biol Res; 1986; 225():401-12. PubMed ID: 3097675
    [No Abstract]   [Full Text] [Related]  

  • 3. A new systematic treatment for infertile women with abnormal hormone profiles.
    Fleming R; Adam AH; Barlow DH; Black WP; MacNaughton MC; Coutts JR
    Br J Obstet Gynaecol; 1982 Jan; 89(1):80-3. PubMed ID: 6800399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation.
    Venturini PL; Remorgida V; Anserini P; De Cecco L
    Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins.
    Charbonnel B; Krempf M; Blanchard P; Dano F; Delage C
    Fertil Steril; 1987 Jun; 47(6):920-4. PubMed ID: 2954858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stimulation of ovarian function with gonadotropins following suppression of endogenous gonadotropin secretion by long-term infusion of the LHRH analog buserelin].
    Geisthövel F; Bliefert R; Geyer H; Breckwoldt M; Sandow J
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):240-5. PubMed ID: 3109997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
    Armitage M; Wilkin T; Dewbury K
    Br Med J (Clin Res Ed); 1987 Jul; 295(6590):96. PubMed ID: 3113653
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins.
    Fleming R; Haxton MJ; Hamilton MP; McCune GS; Black WP; MacNaughton MC; Coutts JR
    Br J Obstet Gynaecol; 1985 Apr; 92(4):369-73. PubMed ID: 3921050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma melatonin profile and hormonal interactions in the menstrual cycles of anovulatory infertile women treated with gonadotropins.
    Tang PL; Chan TY; Tang GW; Pang SF
    Gynecol Obstet Invest; 1998; 45(4):247-52. PubMed ID: 9623790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist.
    Donderwinkel PF; Schoot DC; Pache TD; de Jong FH; Hop WC; Fauser BC
    Hum Reprod; 1993 Dec; 8(12):2027-32. PubMed ID: 8150898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.
    Homburg R; Eshel A; Kilborn J; Adams J; Jacobs HS
    Hum Reprod; 1990 Jan; 5(1):32-5. PubMed ID: 2108981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles.
    Lanzone A; Fulghesu AM; Villa P; Guida C; Guido M; Nicoletti MC; Caruso A; Mancuso S
    Fertil Steril; 1994 Jul; 62(1):35-41. PubMed ID: 8005301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
    Fogel M; Rubin BL; Ossowski R
    Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to improve ovarian response by combined gonadotropin-releasing hormone agonist and gonadotropin therapy.
    Bider D; Kokia E; Lipitz S; Blankstein J; Mashiach S; Serr DM; Ben-Rafael Z
    Gynecol Obstet Invest; 1990; 29(3):192-6. PubMed ID: 2113505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ovulation with various regimens of luteinizing hormone-releasing hormone administration.
    Gual C
    Basic Life Sci; 1974; 4(PART A):355-70. PubMed ID: 4614788
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH; Sy L; Cannon W
    Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.